Search research articles
Contact Us
Filters
Showing results (201-210 of 297) with videos related to
Page
of 30
Sort By:
Respiratory Care
|
December 17, 2020
High-Flow Nasal Cannula Therapy in COVID-19: Using the ROX Index to Predict Success
Abhimanyu Chandel, Saloni Patolia, A Whitney Brown, et al.
Chest
|
January 2, 2009
Treatment of sarcoidosis-associated pulmonary hypertension. A two-center experience
Christopher F Barnett, Eric J Bonura, Steven D Nathan, et al.
Pulmonary Circulation
|
August 20, 2025
Significance of Pulmonary Vascular Dysfunction in Chronic Obstructive Pulmonary Disease
Steven D Nathan, Lucilla Piccari, Steven H Abman, et al.
Annals of the American Thoracic Society
|
September 24, 2020
Surgical Lung Biopsy for Interstitial Lung Disease. Safety and Feasibility at a Tertiary Referral Center
Jean Pastre, Sandeep Khandhar, Scott Barnett, et al.
Frontiers in Medicine
|
July 2, 2021
Automated Digital Quantification of Pulmonary Fibrosis in Human Histopathology Specimens
Lauren C Testa, Yvon Jule, Linnea Lundh, et al.
Chest
|
January 17, 2008
Validation of a method to screen for pulmonary hypertension in advanced idiopathic pulmonary fibrosis
David A Zisman, Arun S Karlamangla, Steven M Kawut, et al.
The European Respiratory Journal
|
December 15, 2018
Pulmonary hypertension in chronic lung disease and hypoxia
Steven D Nathan, Joan A Barbera, Sean P Gaine, et al.
Journal of Clinical Medicine
|
July 2, 2021
Differentiation of Idiopathic Pulmonary Fibrosis from Connective Tissue Disease-Related Interstitial Lung Disease Using Quantitative Imaging
Jonathan H Chung, Ayodeji Adegunsoye, Brenna Cannon, et al.
Chest
|
September 17, 2022
Inhaled Treprostinil Dosage in Pulmonary Hypertension Associated With Interstitial Lung Disease and Its Effects on Clinical Outcomes
Steven D Nathan, Chunqin Deng, Christopher S King, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
August 4, 2021
Donor derived cell free DNA% is elevated with pathogens that are risk factors for acute and chronic lung allograft injury
Katrina Bazemore, Michael Rohly, Nitipong Permpalung, et al.
Page
of 30
Search research articles
Search
Showing results (201-210 of 297) with videos related to
Sort By:
Page
of 30
Respiratory Care
|
December 17, 2020
High-Flow Nasal Cannula Therapy in COVID-19: Using the ROX Index to Predict Success
Abhimanyu Chandel, Saloni Patolia, A Whitney Brown, et al.
Chest
|
January 2, 2009
Treatment of sarcoidosis-associated pulmonary hypertension. A two-center experience
Christopher F Barnett, Eric J Bonura, Steven D Nathan, et al.
Pulmonary Circulation
|
August 20, 2025
Significance of Pulmonary Vascular Dysfunction in Chronic Obstructive Pulmonary Disease
Steven D Nathan, Lucilla Piccari, Steven H Abman, et al.
Annals of the American Thoracic Society
|
September 24, 2020
Surgical Lung Biopsy for Interstitial Lung Disease. Safety and Feasibility at a Tertiary Referral Center
Jean Pastre, Sandeep Khandhar, Scott Barnett, et al.
Frontiers in Medicine
|
July 2, 2021
Automated Digital Quantification of Pulmonary Fibrosis in Human Histopathology Specimens
Lauren C Testa, Yvon Jule, Linnea Lundh, et al.
Chest
|
January 17, 2008
Validation of a method to screen for pulmonary hypertension in advanced idiopathic pulmonary fibrosis
David A Zisman, Arun S Karlamangla, Steven M Kawut, et al.
The European Respiratory Journal
|
December 15, 2018
Pulmonary hypertension in chronic lung disease and hypoxia
Steven D Nathan, Joan A Barbera, Sean P Gaine, et al.
Journal of Clinical Medicine
|
July 2, 2021
Differentiation of Idiopathic Pulmonary Fibrosis from Connective Tissue Disease-Related Interstitial Lung Disease Using Quantitative Imaging
Jonathan H Chung, Ayodeji Adegunsoye, Brenna Cannon, et al.
Chest
|
September 17, 2022
Inhaled Treprostinil Dosage in Pulmonary Hypertension Associated With Interstitial Lung Disease and Its Effects on Clinical Outcomes
Steven D Nathan, Chunqin Deng, Christopher S King, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
August 4, 2021
Donor derived cell free DNA% is elevated with pathogens that are risk factors for acute and chronic lung allograft injury
Katrina Bazemore, Michael Rohly, Nitipong Permpalung, et al.
Page
of 30